Neutral
Last updated: 2026-04-14 20:27:48 ET
Albertsons’s stock was falling Tuesday after a sales miss and an announcement that the grocery-store chain has reached a $774 million settlement to ...
What a dietitian would eat in a day on GLP-1s to get enough protein, fiber, and nutrients
The GLP-1 market is growing fast. Here’s how much the most popular medications will cost you.
Eli Lilly loses share in India’s GLP‑1 market as cheap semaglutide generics surge, while Novo holds steady after deep price cuts to defend Ozempic...
Apparel retailers could see an up to $13 billion annual boost in spending because of GLP-1 drugs, according to an estimate by equity research firm Ber...
Novo Nordisk launched the high dose version of its GLP-1 injection at a price that’s $50 lower than the one for Eli Lilly’s competing drug.
CNBC spoke with five U.S. patients who recently started the pill following its launch and have varying initial experiences with the drug.
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE